(Q28292544)

1

0 references

K T Kivistö

2

0 references

J T Backman

3

0 references

T S Lamberg

4

0 references

P J Neuvonen

Clinical Pharmacology & Therapeutics

5

0 references

language of work or name

English

0 references

publication date

December 1998

0 references

published in

0 references

volume

64

0 references

page(s)

655-60

0 references

issue

6

0 references

cites work

Trough concentrations of cyclosporine in blood following administration with grapefruit juice

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990056-X

Grapefruit juice--felodipine interaction: mechanism, predictability, and effect of naringin

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990056-X

Effect of grapefruit juice and naringin on nisoldipine pharmacokinetics

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990056-X

The effect of grapefruit juice on cyclosporine and prednisone metabolism in transplant patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990056-X

Grapefruit juice alters terfenadine pharmacokinetics, resulting in prolongation of repolarization on the electrocardiogram

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990056-X

Interaction between grapefruit juice and midazolam in humans.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990056-X

Grapefruit juice greatly increases serum concentrations of lovastatin and lovastatin acid

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990056-X

Grapefruit juice increases felodipine oral availability in humans by decreasing intestinal CYP3A protein expression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990056-X

Buspirone. A preliminary review of its pharmacological properties and therapeutic efficacy as an anxiolytic

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990056-X

Comparative effects of a repeated dose regime of diazepam and buspirone on subjective ratings, psychological tests and the EEG

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990056-X

Distinguishing a benzodiazepine agonist (triazolam) from a nonagonist anxiolytic (buspirone) by electroencephalography: kinetic-dynamic studies.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990056-X

Plasma buspirone concentrations are greatly increased by erythromycin and itraconazole

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990056-X

Simultaneous screening and quantitation of alpidem, zolpidem, buspirone and benzodiazepines by dual-channel gas chromatography using electron-capture and nitrogen-phosphorus detection after solid-phase extraction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990056-X

Effects of verapamil and diltiazem on the pharmacokinetics and pharmacodynamics of buspirone

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990056-X

Metabolism and disposition of buspirone

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990056-X